Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
31 May, 2026, 05.00 PM IST
CEOs are getting ruthless about worker performanceCorporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...
20 May, 2026, 04.22 PM IST
Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
20 May, 2026, 02.53 PM IST
Global Markets | European shares subdued as US-Iran talks stall; corporate earnings on tapEuropean shares were muted on Tuesday as investors braced for a week packed with central bank meetings and corporate earnings, while weighi...
28 Apr, 2026, 03.15 PM IST
Novartis to buy experimental breast cancer drug in up to $3 billion dealSwiss drugmaker Novartis is set to acquire a promising breast cancer drug candidate from US biotech firm Synnovation Therapeutics. The deal...
20 Mar, 2026, 03.52 PM IST
Roche ramps up AI computing capacity with Nvidia chip expansionRoche said the additional hardware would speed up work across its research and development operations, including modelling, data analysis...
17 Mar, 2026, 07.28 AM IST
Novartis signs up to $5.2 billion heart drugs licensing deal with China's ArgoNovartis has entered into a licensing and options agreement with Argo Biopharmaceutical, valued at up to $5.2 billion. The deal encompasses...
03 Sep, 2025, 05.26 PM IST
Moderna plans mix of COVID-19 vaccine doses with new Lonza dealIt has agreed a deal with Swiss-based drugmaker Lonza which said a new drug substance production line in Geleen, Netherlands, will have cap...
02 Jun, 2021, 01.13 PM IST
Roche links with Moderna to include antibody test in COVID-19 vaccine trialRoche said the test can provide quantitative evidence of the presence and levels of antibodies that develop in response to the vaccine cand...
09 Dec, 2020, 01.02 PM IST
Swiss drugmaker Roche says demand for Covid-19 tests exceeds production"The demand exceeds our production," Christoph Franz was quoted as saying in Saturday's paper. The decision on where tests were shipped to ...
27 Jun, 2020, 10.27 PM IST
Roche says prostate cancer drug hit one trial goal, missed anotherSwiss drugmaker Roche said on Friday its experimental medicine ipatasertib hit one goal of a late-stage clinical trial against a small slic...
19 Jun, 2020, 12.06 PM IST
- IPAB dismisses Bayer's stay plea in Nexavar case
IPAB of Chennai has dismissed German pharma major Bayer's plea, seeking a stay on the Compulsory Licence issued to Hyderabad-based drugmake...
18 Sep, 2012, 05.05 AM IST
- Cipla’s patent win against Roche boosts hopes of generic drugmakers
The Delhi HC ruling favouring India’s second largest drugmaker Cipla has come as a shot in the arm for other generic makers who are fightin...
10 Sep, 2012, 11.15 AM IST
- Jupiter Biosciences in talks to buy Swiss pharma co for $10 m
Hyderabad-based Jupiter Biosciences is in talks to buy privately held Swiss pharma company SynphaBase AG for about $10 million as it looks ...
24 Jan, 2011, 06.30 AM IST
- Nestle starts 10 bln franc share buyback programme
Nestle, the world's biggest food group, will start its 10 billion Swiss franc ($8.85 billion) share buyback programme on June 29 and expect...
18 Jun, 2010, 12.21 PM IST
- Swiss drugmaker Roche completes Genentech takeover
Swiss pharmaceutical giant Roche said it has completed its $46.8 billion takeover of California-based biotech firm Genentech.
26 Mar, 2009, 01.19 PM IST
- Swiss drugmaker Novartis to cut 2,500 jobs
Swiss drugmaker Novartis said plans to cut 2,500 jobs in a restructuring programme aimed at generating yearly cost savings of 1.6 billion d...
13 Dec, 2007, 01.10 PM IST